Weld Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Weld Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,063	Closed	-$136K	–	617
2020 Q4	$136K	Buy	+10,063	New	+$122K	0.05%	434
2020 Q2	–	Sell	-14,780	Closed	-$200K	–	686
2020 Q1	$200K	Buy	+14,780	New	+$280K	0.1%	318
2019 Q2	–	Sell	-27,469	Closed	-$1.3M	–	982
2019 Q1	$1.3M	Buy	+27,469	New	+$1.21M	0.24%	141

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Weld Capital Management's AERI Position: Q1 2021 in Review

Weld Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 10,063 shares — an estimated $136K sold.

Weld Capital Management first reported a position in AERI in Q1 2019 and held it in 3 quarters. The position peaked at $1.3M in Q1 2019. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.

Weld Capital Management reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Weld Capital Management sold 10,063 Aerie Pharmaceuticals shares in Q1 2021, an estimated $136K.
Weld Capital Management first reported a position in Aerie Pharmaceuticals in Q1 2019 and held it in 3 quarters.
Weld Capital Management's Aerie Pharmaceuticals position peaked at $1.3M in Q1 2019.
158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.